Methylene Blue
| Category | Compounds |
|---|---|
| Also known as | Methylthioninium Chloride, MB |
| Last updated | 2026-04-14 |
| Reading time | 3 min read |
| Tags | nootropicmitochondrialredoxsmall-moleculeresearch |
Overview
Methylene Blue (methylthioninium chloride) is a century-old phenothiazine dye that remains one of the few drugs FDA-approved for methemoglobinemia. It also holds a notable place in infectious disease history (including as an early antimalarial) and appears in research across neurology, oncology, and psychiatry. In the nootropic research community it is discussed primarily for its effects on mitochondrial respiration and oxidative stress.
Mechanistically, low concentrations of methylene blue can act as an alternative electron carrier in the mitochondrial electron transport chain, bypassing certain complex blockages and supporting ATP production. This property places it conceptually near mitochondrially targeted peptides like SS-31 and MOTS-c, and NAD+ biology research represented by NAD precursors.
Methylene blue is not a peptide, but it is commonly catalogued in peptide research contexts because of its overlap with mitochondrial and neuroenergetic research themes alongside peptides like Humanin and compounds like Bromantane and Noopept.
Structure / Chemistry
Methylene blue is a small heterocyclic cation (3,7-bis(dimethylamino)phenothiazin-5-ium chloride, MW ~319.85 g/mol). It is intensely blue in its oxidized form and colorless when reduced to leucomethylene blue, a redox cycling that underlies much of its biology.
Mechanism of Action
Methylene blue has multiple dose-dependent actions. At low micromolar concentrations, it donates and accepts electrons within mitochondria, increasing cytochrome oxidase activity and ATP production. It inhibits nitric oxide synthase and monoamine oxidase at relevant concentrations, and shows amyloid- and tau-related activity that has motivated investigation in neurodegenerative disease. It also converts methemoglobin back to hemoglobin, the basis of its approved use.
Research Summary
| Area | Finding | Reference |
|---|---|---|
| Mitochondria | Low-dose MB enhances cytochrome oxidase activity | Callaway et al., Neurosci Res 2004 |
| Cognition | MB improved memory retention in rodent tasks | Riha et al., Brain Res 2005 |
| Human imaging | MB altered fMRI brain activity in a memory task | Rodriguez et al., Radiology 2016 |
| Alzheimer's | Methylthioninium derivatives studied in trials | Wischik et al., J Alzheimers Dis 2015 |
| Methemoglobinemia | Established reversal agent | Wright et al., Ann Emerg Med 1999 |
Pharmacokinetics
Methylene blue is orally and intravenously bioavailable with an elimination half-life on the order of multiple hours. Hormetic/biphasic dosing is a recurring theme in cognitive research — low doses may be beneficial while higher doses can be pro-oxidant. Specific doses are historical research values, not guidance.
Common Discussion Topics
- Biphasic/hormetic dose-response in nootropic research.
- MAO inhibition and interaction risks with serotonergic drugs.
- Use as mitochondrial electron carrier vs. its pigment properties.
- Overlap with SS-31 and MOTS-c in mitochondrial research.
- Pharmaceutical vs. industrial grade purity distinctions.
Related Compounds
Sourcing research-grade compounds
Obtaining high-purity, research-grade Methylene Blue requires verified and trusted suppliers with third-party COA testing and transparent sourcing practices.
White Market Peptides — Verified Supplier →Join the discussion
See how the community is discussing Methylene Blue. Share your experience, ask questions, and explore protocols on PepAtlas.
Related entries
- Bromantane— Bromantane is a Russian-developed adamantane derivative studied as an atypical psychostimulant and adaptogen with mild dopaminergic effects.
- MOTS-c— A 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA, identified as an exercise mimetic that activates AMPK signaling and regulates metabolic homeostasis.
- NAD+ Precursors— Compounds that elevate cellular NAD+ levels, including NMN and NR, studied for their roles in sirtuin activation, mitochondrial function, and aging biology.
- Noopept— Noopept is a synthetic proline-containing dipeptide nootropic developed in Russia, often discussed as a more potent, orally active analog of piracetam.
- SS-31 (Elamipretide)— A synthetic mitochondria-targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing electron transport chain function — the most clinically advanced mitochondria-targeted peptide, with Phase III trial data in Barth syndrome and heart failure.